Effects Of DP-b99 On Neurological Function In Subjects With Acute Ischemic Hemispheric Stroke

Completed

Phase 2 Results

Summary of Purpose

This study will examine if DP-b99 can improve neurological function (for example strength and coordination) in the 3 months after an acute stroke

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 November 2007.

1 Feb 2005 11 Sep 2005 Unavailable 1 Oct 2006 1 Nov 2007 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Tami Horovitz, PhD Business Development Manager D-Pharm Ltd Tel: 972 89385100 Fax: 972 89300795 Email: tami@dpharm.com

    grosenberg@dpharm.com